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Background: Gorham’s disease is a rare osteolytic disorder characterized by progressive resorption of bone and
replacement of osseous matrix by a proliferative non-neoplastic vascular or lymphatic tissue. A standardized treatment
protocol has not yet been defined due to the unpredictable natural history of the disease and variable clinical
presentations. No single treatment has proven to be superior in arresting the course of the disease. Trials have
included surgery, radiation and medical therapies using drugs such as calcium salts, vitamin D supplements and
hormones. We report on our advantageous experience in the management of this osteolyic disorder in a case
when it affected only the skull vault. A brief review of pertinent literature about Gorham’s disease with skull
involvement is provided.
Case presentation: A 25-year-old Caucasian male presented with a skull depression over the left fronto-temporal
region. He noticed progressive enlargement of the skull defect associated with local pain and mild headache. Physical
examination revealed a tender palpable depression of the fronto-temporal convexity. Conventional X-ray of the skull
showed widespread loss of bone substance. Subsequent CT scans showed features of patchy erosions indicative of an
underlying osteolysis. MRI also revealed marginal enhancement at the site of the defect. The patient was in need of a
pathological diagnosis as well as complex reconstruction of the afflicted area. A density graded CT scan was done to
determine the variable degrees of osteolysis and a custom made allograft was designed for cranioplasty preoperatively
to allow for a single step excisional craniectomy with synchronous skull repair. Gorham’s disease was diagnosed based
on histopathological examination. No neurological deficit or wound complications were reported postoperatively. Over
a two-year follow up period, the patient had no evidence of local recurrence or other systemic involvement.
Conclusions: A single step excisional craniectomy and cranioplasty can be an effective treatment for patients with
Gorham’s disease affecting the skull vault only. Preoperative planning by a density graded CT aids to design a synthetic
bone flap and is beneficial in skull reconstruction. Systemic involvement is variable in this patient’s population.
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Gorham’s disease is a rare and potentially disabling
osteolytic disorder. It is characterized by uncontrolled
proliferation of non-neoplastic vascular or lymphatic tis-
sues, leading to progressive resorption and replacement
of osseous matrix which may extend to the adjacent tis-
sues [1,2]. It was first described by Jackson in 1838 who
reported a case of “boneless arm” and much later* Correspondence: ekasper@bidmc.harvard.edu
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unless otherwise stated.presented as a distinct clinical syndrome by Gorham and
Stout in 1954, who characterized its main pathological
features [3,4]. Other terms such as “massive osteolysis”,
“disappearing bone disease” and “phantom bone disease”
have also been used [5,6]. Gorham’s disease usually oc-
curs in children and young adult patients, most com-
monly in the 2nd and 3rd decades [7-9] although any
age group may be affected (with cases reported spanning
from 1.5 to 72 years) [8] and without any race or gender
predilection [2,10].
Histologically, Gorham’s disease is characterized by in-
flammatory osteolysis of bony segments which are thenhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[11]. These osteolytic characteristics may be accompan-
ied by several types of non-neoplastic developmental
vascular malformations, including capillary, venous and
lymphatic malformations without endothelial cell prolif-
eration [10,12]. Here, we present a case of Gorham’s dis-
ease affecting only the skull vault which was managed by
a single-stage craniectomy and skull reconstruction,
using a synthetic bone flap generated preoperatively via
distinct computer aided planning technique. To put this
into an appropriate context we included a review of the
pertinent literature.
Case presentation
A 25-year-old Caucasian man presented with a skull de-
fect over the left frontotemporal region that had pro-
gressively enlarged over a 3-year period. He complained
of mild dull local aching headaches with short term
memory impairment of one year duration, occasional
visual symptoms, and subjectively decreased hearing.
Symptoms were explained by the polysubstance abuse
and the patient’s past medical history of depression.
General physical examination was unremarkable with
the exception of a clearly visible osseous depression of
the left frontoparietotemporal region associated with
mild tenderness on palpation and interspersed softness
embedded in a thinned but firm skull. The patient was
neurologically intact. X-ray of the skull (Figure 1A & B)
showed widespread loss of calvarial structure secondary to
an osteolytic process. Subsequent head CT scan
(Figure 2A, B & F) showed the typical features of a
patchy erosive osteolysis of the left frontoparietotemp-
toral skull region indicative of an active underlying
process. Coronal, sagittal and lambdoid sutures were
shown to be patent radiographically in skull-scoutsFigure 1 Plain skull films as obtained from CT-scouts: (A) Anteroposteri
with a view C) of the upper cervical spine (lateral view). No other lesions
Sagittal and coronal sutures are visible.(Figure 1A & B) and CT-cuts (Figure 3A & B) in order
to exclude craniosynostosis. Post-contrast MRI study
revealed marginal enhancement of the calvarial defect
with no evidence of brain invasion or soft tissue com-
ponent. (Figure 2C & D) Bone survey as well as chest
x-ray were done to exclude skeletal and pulmonary in-
volvement, respectively. Furthermore, the metabolic
and chemical labs’ profile of the patient did not reveal
any abnormality indicative of metabolic or endocrino-
logic disease. This study was approved by the institu-
tional review board (IRB) of our hospital using an IRB
protocol number (2013-P-000253/3). An informed pa-
tient’s consent was obtained to submit this article to
the journal in order to be published.
Based on a density graded CT scan, the severity of ero-
sion at the affected skull region was determined. A custom
made cranioplasty allograft was designed preoperatively
(Figure 4) using a digital computerized software (Stryker®,
Kalamazoo, Michigan) to define the size, site and shape of
the synthetic bone flap enabling a single-staged surgery of
excisional craniectomy, allograft duraplasty and synchron-
ous skull reconstruction. (Figure 3) The pre-fabricated im-
plant was made of Poly Methyl Methacrylate (PMMA).
This patient’s pre-manufactured implant configuration
was designed using specific software (Mimics, Materialise
Company, Belgium) which generated allograft models
based on variable degrees of osteolysis seen in the affected
part of the skull bone on CT. The extent of calvarial
bone to finally be excised and replaced was decided
from a density-graded CT scan. To this end, we ran-
domly selected 10 representative points within diseased
and healthy skull regions, and obtained the respective
Hounsfield units. This yielded a range of bone density
values. The mean value for diseased bone was 342 HU
(range: 158 to 643 Hounsfield units) whereas the meanor and (B) lateral projections show the skull preoperatively together
were evident, nor did we observe cervical fractures or misalignment.
Figure 2 Preoperative images. A. and B. Preoperative CT of the skull bone window axial and coronal respectively showing frontparietotemporal
bone thinning, erosion and defect. C. and D. Preoperative MRI brain T1-WI with contrast showing the marginal enhancement. E. and F. CT skull
with 3D reconstruction showing the variable degrees of osteolysis from outside and inside respectively.
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1630 units), respectively.
To generate the final allograft construct, we then
color-coded the prospective craniectomy area on the CT
scan using the highest obtained density value of diseased
skull (643 Hounsfield units). We used this particular
value as a cut off since its density was about half that of
the mean value obtained from the density measurements
of healthy bone. A visual overlay was then used to con-
firm that the chosen implant shape matched all areas of
diseased bone.
Surgery as such was then performed in a standard
fashion. The patient underwent general endotracheal
anesthesia and was position supine in three point skel-
etal fixation pins (Mayfield). Preoeprative density graded
CT and MRI data were loaded on an intraoperative
image guidance system (BrainLab) to map the affected
area onto the scalp. The incision was planned accord-
ingly and a conventional myocutaneous flap was raised.
The affected area was visually identified. The optimal ex-
tent of the resection was taken from the CT and
sketched onto the bony surface. For corroboration, the
pre-generated bone allograft was put as a stencil onto
the marked and affected skull area and it was confirmedthat it could be used for the ensuing craniectomy. This
way we could excise a bone segment that matched pre-
cisely the custom made implant for later repair. After
standard craniectomy employing a side cutting saw
(Anspach, DePuy; West Chester, PA), we separated the
affected bone from the underlying layer of dura and
repaired a very small dural defect with a pericranial
autograft before we proceeded immediately with vault
reconstruction using the prefabricated bony allograft
(see Figure 5). The wound was hemostased and closed in
layers without the need of subgaleal drains. The patient
recovered from anesthesia immediately in the operative
room. The postoperative period was uneventful and the
patient showed no neurological deficit.
Pathology
Routine hematoxylin and eosin was performed on
formalin-fixed, paraffin-embedded sections after decalci-
fication of the submitted bone specimen. The sections
revealed distinct areas of bone resorption with replace-
ment by fibrous tissue with variable degrees of vascular-
ity and collagen depositions (Figure 6A). In focal areas
adjacent to zones of active bone resorption were numer-
ous thin-walled, predominantly capillary-sized blood
Figure 3 Postoperative CT skull images following excision and
reconstruction. A) axial view of bone window, B) coronal view of
bone window and C) CT skull with 3D reconstruction.
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sorption were composed of densely collagenized fibrous
tissue with interdispersed small blood vessels (Figure 6C).
Beyond these characteristic features there were patchy
areas with chronic inflammatory cells, including foamy
macrophages (Figure 6D).
The postoperative period was uneventful without local
wound complications or any neurological deficit and the
patient was discharged four days postoperatively. Over a
two-year follow up period, the patient did not show any
evidence of resorption of the adjacent skull bone or any
other skeletal involvement.
Discussion
Gorham’s disease is a non-hereditary progressive osteo-
lytic disorder that typically affects bones with subsequent
lymphatic vascular malformation [13,14]. Gorham’s dis-
ease can be monostotic or polyostotic, however multi-
centric involvement is rare [15,16]. The most commonly
involved sites are the mandible (15%), scapula (10%), ribs
(12%), humerus (8%), pelvis (10%), femur (11%) [17] and
less commonly the skull [18]. Clinical presentations vary
based on the site of bone involvement and presence of
systemic manifestations. To our knowledge, less than 30cases of Gorham’s disease with any skull involvement,
including this case report, have been reported in the
literature.
Table 1 Published case reports of Gorham’s disease in-
volving the skull [15,18-38].
Pathogenesis
The pathogenesis of Gorham’s disease remains poorly
understood and a number of possible causes have been
reported in literature. While Radhakrishnan and Rockson
[6] suggested that Gorham’s disease is a disease of dis-
ordered lymphangiogenesis, Aviv and colleagues [39]
suggested that it might occur independently from dis-
seminated lymphangiomatosis, therefore representing
two varieties of a rare disease etiology. Pathophysio-
logical aspects regarding the presence or absence of os-
teoclasts in pathological tissue [40] as well as effects of
hyperemia and changes in local pH-stimulating hydro-
lytic enyzmes remain controversial [41].
While Gorham and Stout [42] originally suggested that
“osteoclastosis” was not a necessary feature, Foult and
colleagues [43] pointed out that osteolysis occurred sec-
ondary to angiomatosis, and Spieth and colleagues [44]
demonstrated a clear relationship between osteoclast ac-
tivity and Gorham’s disease. This is further corroborated
by the work of Möller and colleague [45], who described
a large number of multinucleated osteoclasts with hyper-
active resorptive function in his patients.
To determine the presence of blood and lymphatic
vessel markers on the endothelial cells of the patho-
logical proliferating vasculature in Gorham’s disease
Hagendorn and coworkers [46] stained specimens for
specific makers such as panendothelial marker CD 31
(platelet endothelial cell adhesion molecule), lymphatic
vessel endothelial hyaluronan receptor-1 (LYVE-1), and
VEGF receptor (VEGFR)-3. Over 90% of endothelial
cells expressed CD-31 and were also found staining posi-
tive for LYVE-1, suggesting that the proliferating vascu-
lature associated with Gorham’s lymphangiomatosis
consists predominantly of lymphatic endothelium [46].
Diagnosis
Clinical diagnosis
The reported clinical manifestations of Gorham’s dis-
ease were quite variable and largely depend on the site
and extent of involvement. The presentation may be
limited to local symptoms, such as pain and swelling of
the affected extremity, soft tissue atrophy, and weak-
ness of the involved limb or pathological fractures.
However, systemic involvement, such as respiratory or
neurological complications, was also frequently re-
ported [7-9,16,44,47,48].
The neurological symptoms of Gorham’s disease vary
greatly. Skull involvement may lead to progressive
Figure 4 Preoperative planning. A. Variable densities of the resorbed bone are illustrated in different colors based upon CT. B. The measurements of
the expected bone defect after removal of all regions (1, 2 and 3) giving an area of 90 × 110 mm which is the size of the designed implant synthetic
bone flap. C. The expected final design of the bone flap replacing the defect and preserving the same skull contour.
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or recurrent episodes of meningitis secondary to
chronic cerebrospinal fluid leakage [5,49]. Furthermore,
some patients with temporal bone involvement may
have auricular fullness, tinnitus, hearing loss or deaf-
ness [15,34,37]. Vertebral column involvement leading
to pathological fractures, spine deformities and/or para-
plegia has also been reported [7,24,50].
Radiologic diagnosis
Skull X-rays may initially show radiolucent foci which
may subsequently extend into progressive dissolution
and disappearance of a portion of the calvarial bone[24]. The osteolysis may extend to the contiguous bone
and cross the intervening joint [24]. Kotecha and col-
leagues [51] emphasized the advantage of using quanti-
tative computed tomography in the assessment of bones
in patients with Gorham’s disease [52]. Among other
benefits, it assesses the stage of the disease and aids in
the decision-making processes at the time of initiating a
particular treatment regimen also allowing to monitor
individual patient response to any given therapy [53].
In addition to CT scans, thin cut fat-suppressed MRI
T1-weighted contrast enhanced images help in visualiz-
ing a reticular pattern typical for the vascular compo-
nent of the lesion [38].
Figure 6 Histopathology. A) Replacement of bone by fibrous tissue with variable amount of collagen deposition and vascularity. (H&E, 10X
objective) B) Presence of marked number of thin-walled vessels next to an area of active bone resorption. The blood vessels are predominantly
capillaries, but smaller arterioles and venules are also seen. (H&E, 10X objective) C) Bone replacement by dense fibrous tissue with occasional small
blood vessels. (H&E, 10X objective) D) Patchy area of chronic inflammatory infiltration with scattered foamy macrophages. (H&E, 40X objective).
Figure 5 Intraoperative images. A. Exposure of the bony lesion following temporalis muscle separation. B. Final view following surgical excision and
reconstruction using a synthetic bone flap fixed to the surrounding apparently healthy bone with miniplates and screws.
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Table 1 Review of reported cases of cranial involvement in Gorham’s syndrome
Reference Age of
onset
Gender Location Symptoms Treatment F/U outcome
Chiang et al. [19] 46 Male Occipital bone No neurol. Symptoms. - -
Wildförster et al. [21] - female Squamofrontal No neurol. symptoms -
Zhang et al. [20] 40 Male Parietooccipital region No neurol. symptoms Stable
Kawasaki et al. [22] 29 Female Left temporal bone, facial
mandibular and vertebral
bones
Pain, hoarsenes, swallowing disturbace,
postural instability of the neck and
associated dyspnea and dysphagia,
deafness and dumbness, left facial palsy,
loss of vision
At age 34 years radiation therapy (total, 31 Gy) was
performed. At age 35 years, further irradiation of the
skull base (total, 28 Gy) was tried, but the osteolytic
lesion expanded further. At the age of 36 years
posterior cranio-vertebral fixation, tracheotomy and
gastrostomy were performed because of postural
instability of the neck and
Death
Chai et al. [23] 38 Male Fronto-parietal - Cranioplasty
Lo et al. [24] 23 Male Left parietal region No neurol. symptoms Left parietal craniectomy was performed,
Reconstructive surgery with artificial bone graft will
be scheduled in the next hospital course, 3 months.
Stable
Papeix et al. [25] 40 Male Parietal pone No neurol. symptoms Radiotherapy and surgery -
Rao et al. [26] 20 Female Left parietal bone No neurol. symptoms - -
Frankel et al. [27] 14 Female Calvarium Rhinorrhoe, sensorineural hearing loss,
immobile left palate, atrophy of the left
side of the tongue with fasciculations
2340 cGy in 13 fractions 12 months,
stabilisation
and sclerosis
Hasegawa et al. [28] 49 Male Left parietal bone Headache Surgery -
Parihar et al. [29] 35 Female Left parietal bone No neurol. Symtoms Left parietal craniotomy, cranioplasty -
Iyer et al. [30] 58 Female Frontal bone Headache, vomiting, delirium,
rhinorrhoea, meningitis
Pt. refused surgery -
Girisha et al. [31] 16 months Female Calvaria Developmental delay, failure to thrive - -
Kurczynski et al. [32] 14 Female Left orbit, zygoma, mandible,
sphenoid, and occiput
Left enophthalmia Radiotherapy with 2000 rad to the entire skull,
mandible, and upper cervical vertebrae
24 months, no further
progression, slight
remineralization
Khorsovi et al. [33] 62 Male Occipital bone No neurol. symptoms Total of 4000cGy 24 months, arrest of
disease process with
new bone formation
Mawk et al. [18] 7 Male Right skull base and cervical
spine
Neck pain, lymphatic fluid within middle
ear spaces and paranasal sinuses.
Surgery, 4140 cGy 3 months, no clinical
or radiological
progression
Plontke et al. [34] 54 Female Skull Base Right hearing loss Cranio-cervical stabilisation, radiation total
30,6 Gy
8 months, no clinical
or radiological
progression
Girn et al. [15] 2 Female Skull base Clinical signs mimicking raised intracranial
pres- sure and deafness
Halo application disease process did not respond
to palmidronate and radiotherapy ( Five courses of














Table 1 Review of reported cases of cranial involvement in Gorham’s syndrome (Continued)
Schiel et al. [35] 14 Female Posterior wall of the maxillary
sinus, the orbit and base of the
skull as fas as the apwx of the
os petrosus
Right maxillary pain Removal of right palatal mucoperiosteum






2 Male Temporal bone Secondary cerebrospinal fluid (CSF)
leakage
Patient required two surgical interventions. The
second intervention included mastectomy and
placement of a patch and a lumbar drainage
device during 50 days, after which the leakage
ceased
-
Mowry et al. [37] 29 Female Left temporal bone Intermittent aural fullness, egophony,
tinnitus bilaterally
- -
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the disease activity as it may demonstrate increased up-
take of radiopharmaceutical agents during initial active
stages of the disease and subsequently show areas of
decreased uptake corresponding to the diminished
bone region in later stages of the disease or in response
to treatment [7,16,44]. Torg and coworkers [12,54]
classified Gorham’s disease progression by radiographic
criteria allowing the differentiation of four sequential
stages:
1. An initial stage in which radiolucent foci resembling
patchy osteoporosis are present.
2. A second stage defined by an increase of bone
deformity along with progressive loss of bone mass.
3. A third stage in which the cortical layer is disrupted
by endothelial invasion into adjacent soft tissues or
joints
4. Lastly a stage characterized by some shrinkage of
the ends of affected bones.
Differential diagnosis and work up
The diagnosis is made via a combination of suspicious
clinical and radiologic data as well as distinct histo-
pathological features in conjunction with the exclusion
of other hereditary, traumatic, metabolic, neoplastic, en-
docrinologic, infectious and inflammatory sources of
osteolyses [55,56].
Although other osteolytic disorders of the skull (such
as multiple myeloma, osteolytic metastases, juvenile
Paget’s disease, eosinophilic granuloma and brown
tumor) may show similar imaging findings, the CT,
MRI and Tc-99 findings in combination with the long
asymptomatic clinical course facilitate the differenti-
ation of Gorham’s disease. Identifying areas of distinct
vascular or lymphatic proliferation in early disease
stages or the transformation to fibrous tissue in late
disease stages can be achieved by generous biopsies of
the affected bone and is essential for the unequivocal
diagnosis of Gorham’s disease [42,57].
To this end, Heffez and colleagues [58] published a
case report in which they suggested specific criteria dis-
tinguishing Gorham’s disease from other diseases of
bony destruction which include:
 Positive biopsy with the presence of angiomatous
tissue
 Absence of cellular atypia
 Minimal or no osteoblastic response or dystrophic
calcifications
 Evidence of local bone progressive osseous
resorption
 Non-expansile, non-ulcerative lesions
 Absence of visceral involvement Osteolytic radiographic pattern
 Negative hereditary, metabolic, neoplastic,
immunologic, or infectious etiology.
The differential diagnosis should further include, but
is not limited to: Paget’s disease, metastases, angiosar-
coma, essential osteolysis and progressive parietal bone
thinning. The latter is an age-related benign process not
associated with metabolic or endocrine abnormalities
and is usually seen on imaging as an incidental finding
[59-61]. In contrast to Gorham’s disease, progressive
thinning of the outer aspect of the vault is the main fea-
ture of biparietal thinning, occurring in pediatric skulls,
although this has also been described in adults [62]. Dif-
ferential diagnosis in children should include: juvenile
fibrosarcoma, juvenile fibromatosis, and chondromyxoid
fibroma [63] in Hajdu-Cheney-syndrome [64] which is a
rare fibroblastic tumor with a predilection for the scalp
of infants.
Management Current treatments are only experimen-
tal as no single treatment has proven to be superiorly
effective in arresting the course of the disease owing to
its unpredictability [2]. Spontaneous arrest [65] or re-
generation [66] of the destroyed bone without treat-
ment has been reported [17,67,68], although the disease
process generally requires multiple treatment attempts.
[15] This may be particularly relevant in cases in which
vital organs such as the spinal cord or lungs are in-
volved, the latter of which can even result in pleural ef-
fusions or chylothorax [69]. However, the progressive
involvement of vital structures in some cases may be
fatal [2,70,71], resulting in an overall mortality of ap-
proximately 13.3% [72]. The prognosis of Gorham’s dis-
ease is otherwise considered to be good when disease is
limited to the limbs or pelvic bones [73-76].
Surgical management
Surgical intervention has been suggested as the method
of choice and includes resection of the lesion and pos-
sible re-grafting using various constructs [16,77-80].
However in the advanced stages of the disease, surgical
procedures may be limited by technical issues such as
the lack of bone substance for fixation of autologous or
alloplastic material [5] or by the extent of systemic in-
volvement. The pre-fabricated implant we used in our
case allows a better cosmetic outcome by providing the
exact natural skull contour compared to the conven-
tional use of mesh and bone cement with excellent pa-
tient’s satisfaction. Although it may take more time
preoperatively to design the compatible shape of the
skull graft, it may save a lot of time intraopreratively to
do both craniectomy and reconstruction in the same
session applying the preformed skull implant precisely
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logical bone. As there is no need for cement preparation
and allograft molding this minimizes intraoperative time.
The implant used in our case was formed of Poly Methyl
Methacrylate (PMMA) which is known to have adequate
impact resistance similar to native skull bone [81] with
less risk of bone resorption compared to autologous
bone flaps [82]. Furthermore, the pre-fabricated PMMA
allows the surgeon to avoid any cement preparation
phase, with its subsequent exothermic reaction which
must be alleviated with cooling-irrigation to minimize
the risk of thermal injury to the underlying structures
such as the dura and/or the brain [83].
A limitation of this technique might be the high cost
of such detailed preoperative planning when using
density-graded CT scanning with 3D reconstruction as
well as designing a patient-specific implant. Beyond this,
its use is highly elective as the lag time makes it not suit-
able for neurosurgical emergencies (e.g. compound de-
pressed skull fractures).
When planning surgery for patients with Gorham’s
disease, certain precautions should be considered, as
they may influence surgical management and strategies.
Anesthesia induction must be done cautiously, as pa-
tients with maxillary or mandibular bone involvement
may have difficult endotracheal intubation, which can
be especially difficult in pediatric age groups. Protec-
tion of the spine is also important during induction and
positioning [8]. Furthermore, postoperative ventilatory
problems have been reported, emphazising that extuba-
tion has to be planned carefully and may involve pro-
longed intensive care management, as chylothorax is a
possible life threatening complication that may occur
even postoperatively.
Reconstruction techniques using prostheses seems to
be effective despite potential obstacles since Woodward
and colleagues [80], Kulenkampff and colleagues [73]
and Paley and coworkers [84] have reported that the
progression of adjacent disease has led to failure of
reconstructions.
Conservative management
Based on the experience of Vinee and colleagues [16],
medical treatment with hormones in combination with
calcium salts and vitamins alone seem to be inefficient.
Other treatment options include drug management and
have been attempted using bisphosphonates, due to their
antiosteoclastic and antiangiogenic activity. Lehmann
and coworkers [85] reported a case of Gorham’s disease
that was successfully treated with bisphosphonates for a
period of 17 years. Hammer and colleagues [86] reported
on bisphosphonate monotherapy (30 mg intravenous/3
months) controlling the disorder during a two year
follow-up period. A successful conservative managementwas also reported by Avelar and colleagues [87], whose
patient received monthly intravenous bisphosphonate in-
fusions (at a dose of 4 mg) in addition to daily calcium
(500mg) and vitamin D (400 UI) over the course of one
year, showing maintenance of bone volume and symp-
tomatic improvement of pain.
Interferon may also be useful because of its antiangio-
genic effects [41] and its use has been reported by Dupond
and colleagues [88] who treated a patient successfully
based on a dosage of 7.5 to 15 million IU 3x/week over 5
years. However, this is contrary to results by Deveci and
coworkers [89] who reported on a patient who died 4
months after the time of diagnosis, after being treated
with interferon alpha-2b and bisphosphonates.
In the case we are presenting here, the patient did not
need to receive any adjuvant radiotherapy or comple-
mentary medical treatment affecting bone remodeling,
since disease was limited to one site only which was
treated by excision. Girn and colleagues [15] reported on
the management of a two-year-old girl with skull base
and cervical spine involvement using radiotherapy and
pamidronate therapy but this regimen resulted in failure
to arrest the disease process and subsequent failure of
surgery providing stabilization. In contrast, Heyd and
colleagues [90], demonstrated that radiation therapy
with the addition of intravenous zoledronic acid therapy
may prevent the progression of the disease in 77% to
80% of cases with applied total doses ranging from 30 to
45 Gy. Similar results were presented in case reports by
other authors (Bruch-Gerharz et al. [12], Johnstun et al.
[91], Browne et al. [92] and Dunbar et al. [93]), who all
came to the conclusion that radiation therapy in moder-
ate doses (40-45 Gy at 1.8 Gy to 2 Gy per fraction) is ef-
fective. Due to the increased risk of radiation-induced
secondary neoplasms and severe delayed toxicity, judi-
cious use of radiation therapy is advised particularly in
young adults and children [94,95].
Conclusion
Gorham’s disease is one of the rare osteolytic disorders
which may affect the skull or any other bone with or
without systemic involvement. Surgical management by
an excisional craniectomy and synchronous skull recon-
struction is an effective and safe modality of treatment
for Gorham’s disease presented with a solitary skull le-
sion. Preoperative planning by a density graded CT and
special software to design a synthetic bone flap allows
for single step reconstruction in this patient’s population
for elective settings and complicated diseases such as
Gorham’s, this seems to yield superior cosmetic results.
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